Search results
Results From The WOW.Com Content Network
University of Pennsylvania. BioNTech. Katalin " Kati " Karikó ( Hungarian: Karikó Katalin, pronounced [ˈkɒrikoː ˌkɒtɒlin]; born 17 January 1955) is a Hungarian-American [ 2] biochemist who specializes in ribonucleic acid ( RNA )-mediated mechanisms, particularly in vitro - transcribed messenger RNA (mRNA) for protein replacement therapy ...
Website. Profile at BioNTech. Signature. Uğur Şahin ( Turkish: [uˈuɾ ʃaː.hin]; born 19 September 1965 [ 3]) is a German oncologist and immunologist. He is the founder and CEO of BioNTech, which developed one of the major vaccines against COVID-19. [ 4][ 5] His main fields of research are cancer research and immunology.
Biontech FY 2023 report [ 1] BioNTech SE ( / biːˈɒntɛk / bee-ON-tek; or / baɪˈɒntɛk / bye-ON-tek[ 2] short for Biopharmaceutical New Technologies) is a German biotechnology company based in Mainz that develops and manufactures active immunotherapies for patient-specific approaches to the treatment of diseases.
You can find instant answers on our AOL Mail help page. Should you need additional assistance we have experts available around the clock at 800-730-2563.
(Reuters) - COVID-19 vaccine maker BioNTech's cancer drug candidate BNT111 showed significant improvement in the response rate in patients with advanced melanoma during a Phase 2 trial, the German ...
June 17, 2024 at 8:33 AM. (Reuters) - Germany's BioNTech SE said in a regulatory filing on Monday the U.S. Food and Drug Administration has placed a partial clinical hold on an early-stage study ...
Pfizer Inc. ( / ˈfaɪzər / FY-zər) [ 3] is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. The company was established in 1849 in New York by two German entrepreneurs, Charles Pfizer (1824–1906) and his cousin Charles F. Erhart (1821–1891).
BioNTech is scheduled to provide detailed full-year 2024 guidance alongside its 2023 financial results on March 20. ($1 = 0.9141 euros) (Editing by Rachel More and Matthias Williams)